Vivanza Biosciences Limited (BOM:530057)

Vivanza Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	84	80	272	752	755	522
Market Cap Growth	-39.13%	-70.69%	-63.88%	-0.34%	44.45%	896.95%
Enterprise Value	179	140	322	807	784	556
Last Close Price	2.10	1.99	6.79	18.80	18.86	13.06
PE Ratio	-	-	49.63	125.69	226.61	693.43
PS Ratio	0.13	1.07	0.97	4.14	6.74	5.26
PB Ratio	1.82	2.01	5.86	18.38	21.61	16.53
P/TBV Ratio	2.82	3.42	9.05	30.62	40.63	34.28
P/FCF Ratio	-	-	13.54	-	30.59	-
P/OCF Ratio	-	-	13.29	-	30.59	-
EV/Sales Ratio	0.27	1.88	1.16	4.44	7.00	5.60
EV/EBITDA Ratio	-	-	28.78	70.90	91.48	193.18
EV/EBIT Ratio	-	-	29.10	71.06	92.28	200.01
EV/FCF Ratio	-	-	16.07	-	31.78	-
Debt / Equity Ratio	2.20	2.18	1.12	1.96	1.58	0.11
Debt / EBITDA Ratio	606.72	-	4.61	7.03	6.43	1.24
Debt / FCF Ratio	-	-	2.58	-	2.23	-
Asset Turnover	1.85	0.42	1.33	0.96	0.93	0.96
Inventory Turnover	17.48	3.20	11.58	6.73	6.26	11.29
Quick Ratio	0.85	0.90	0.96	0.75	0.83	0.60
Current Ratio	1.10	1.35	1.29	1.15	1.31	0.95
Return on Equity (ROE)	-6.41%	-15.67%	12.54%	15.78%	10.01%	2.41%
Return on Assets (ROA)	0.01%	-1.06%	3.30%	3.73%	4.42%	1.67%
Return on Invested Capital (ROIC)	0.02%	-2.76%	8.11%	9.09%	10.91%	2.64%
Return on Capital Employed (ROCE)	0.00%	-4.20%	15.10%	20.50%	14.00%	8.80%
Earnings Yield	-3.64%	-8.47%	2.02%	0.80%	0.44%	0.14%
FCF Yield	-	-31.49%	7.39%	-1.26%	3.27%	-5.33%
Buyback Yield / Dilution	0.01%	-2.32%	2.27%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.